Aging in adipocytes: Potential impact of inherent, depot-specific mechanisms

Fat mass and tissue distribution change dramatically throughout life. Fat depot sizes reach a peak by middle or early old age, followed by a substantial decline, together with fat tissue dysfunction and redistribution in advanced old age. These changes are associated with health complications, including type 2 diabetes, atherosclerosis, dyslipidemia, thermal dysregulation, and skin ulcers, particularly in advanced old age. Fat tissue growth occurs through increases in size and number of fat cells. Fat cells turn over throughout the lifespan, with new fat cells developing from preadipocytes, which are of mesenchymal origin. The pool of preadipocytes comprises 15-50% of the cells in fat tissue. Since fat tissue turns over throughout life, characteristics of these cells very likely have a significant impact on fat tissue growth, plasticity, function, and distribution. The aims of this review are to highlight recent findings regarding changes in preadipocyte cell dynamics and function with aging, and to consider how inherent characteristics of these cells potentially contribute to age- and depot-dependent changes in fat tissue development and function.

[1]  J. Després,et al.  Is visceral obesity the cause of the metabolic syndrome? , 2006, Annals of medicine.

[2]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[3]  Douglas L. Rothman,et al.  Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.

[4]  M. Jensen,et al.  Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. , 2005, American journal of physiology. Endocrinology and metabolism.

[5]  R. I. Gregerman.  Aging and hormone-sensitive lipolysis: reconciling the literature. , 1994, Journal of Gerontology.

[6]  M. Wabitsch,et al.  Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. , 1989, The Journal of clinical investigation.

[7]  A. Welm,et al.  CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. , 1999, Nucleic acids research.

[8]  P. Pilch,et al.  Reconstitution of Insulin-sensitive Glucose Transport in Fibroblasts Requires Expression of Both PPARγ and C/EBPα* , 1999, The Journal of Biological Chemistry.

[9]  L. Qiang,et al.  Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter. , 2006, The Journal of biological chemistry.

[10]  Nikolai A. Timchenko,et al.  Epidermal Growth Factor Receptor Stimulation Activates the RNA Binding Protein CUG-BP1 and Increases Expression of C/EBPβ-LIP in Mammary Epithelial Cells , 2004, Molecular and Cellular Biology.

[11]  E. Dax,et al.  Adipocyte Hormone Responsiveness and Aging in the Rat: Problems in the Interpretation of Aging Research , 1984, Journal of the American Geriatrics Society.

[12]  Youngsoo Kim,et al.  Identification of novel PPARgamma target genes in primary human adipocytes. , 2006, Gene.

[13]  D. Dobson,et al.  Preadipocyte Function and Aging: Links Between Age‐Related Changes in Cell Dynamics and Altered Fat Tissue Function , 1997, Journal of the American Geriatrics Society.

[14]  K. Flegal,et al.  Aim for a healthy weight: what is the target? , 2001, The Journal of nutrition.

[15]  Mary L Bouxsein,et al.  Mechanisms of Disease: is osteoporosis the obesity of bone? , 2006, Nature Clinical Practice Rheumatology.

[16]  M. Jensen,et al.  Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[17]  M. Lane,et al.  CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Gimble,et al.  CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter. , 1997, Biochemical and biophysical research communications.

[19]  B. Spiegelman,et al.  Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. , 1996, Molecular endocrinology.

[20]  J. Hershey,et al.  Age-specific CUGBP1-eIF2 Complex Increases Translation of CCAAT/Enhancer-binding Protein β in Old Liver* , 2006, Journal of Biological Chemistry.

[21]  J. Kirkland,et al.  Adipogenesis and aging: does aging make fat go MAD? , 2002, Experimental Gerontology.

[22]  H. Shu,et al.  TRAF7 Potentiates MEKK3-induced AP1 and CHOP Activation and Induces Apoptosis* , 2004, Journal of Biological Chemistry.

[23]  Mireille André,et al.  Preadipocyte Conversion to Macrophage , 2003, The Journal of Biological Chemistry.

[24]  T. Harris,et al.  Health consequences of obesity in the elderly: a review of four unresolved questions , 2005, International Journal of Obesity.

[25]  Michael Lehrke,et al.  The Many Faces of PPARγ , 2005, Cell.

[26]  C. Zahnow,et al.  Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells. , 2004, Molecular and cellular biology.

[27]  X. Matías-Guiu,et al.  Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV‐1‐infected patients: potential role in subcutaneous adipocyte apoptosis , 2005, European journal of clinical investigation.

[28]  Jeffrey B. Boord,et al.  Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis , 2001, Nature Medicine.

[29]  C. Vigouroux,et al.  Diseases of adipose tissue: genetic and acquired lipodystrophies. , 2005, Biochemical Society transactions.

[30]  A. Bradley,et al.  Impaired energy homeostasis in C/EBP alpha knockout mice , 1995, Science.

[31]  S. O’Rahilly,et al.  Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha. , 2002, Diabetes.

[32]  Z. Wu,et al.  Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids , 1996, Molecular and cellular biology.

[33]  J. Kehayias,et al.  Total body potassium and body fat: relevance to aging. , 1997, The American journal of clinical nutrition.

[34]  R. Evans,et al.  Nuclear receptors and lipid physiology: opening the X-files. , 2001, Science.

[35]  W. Gillon,et al.  Age, anatomic site, and the replication and differentiation of adipocyte precursors. , 1990, The American journal of physiology.

[36]  R. Schwartz,et al.  Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. , 2001, The Journal of nutrition.

[37]  R. Andres,et al.  Contribution of impaired glucose tolerance in subjects with the metabolic syndrome: Baltimore Longitudinal Study of Aging. , 2005, Metabolism: clinical and experimental.

[38]  F. Booth,et al.  Age-associated decrease in muscle precursor cell differentiation. , 2006, American journal of physiology. Cell physiology.

[39]  E. Carlsson,et al.  Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. , 2004, The Journal of clinical investigation.

[40]  R. Unger.  Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine. , 2005, Biochimie.

[41]  Michael Lehrke,et al.  The many faces of PPARgamma. , 2005, Cell.

[42]  A. Newman,et al.  Trunk muscle composition as a predictor of reduced functional capacity in the health, aging and body composition study: the moderating role of back pain. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[43]  S. Farmer,et al.  The Forkhead Transcription Factor FoxC2 Inhibits White Adipocyte Differentiation* , 2004, Journal of Biological Chemistry.

[44]  A. Cicognani,et al.  Measurement of body fat in healthy elderly men: a comparison of methods. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[45]  A. Vidal-Puig,et al.  Lipotoxicity, overnutrition and energy metabolism in aging , 2006, Ageing Research Reviews.

[46]  Ronenn Roubenoff,et al.  Anthropometric assessment of 10-y changes in body composition in the elderly. , 2004, The American journal of clinical nutrition.

[47]  G. Darlington,et al.  CCAAT/enhancer binding protein alpha (C/EBPalpha) is an important mediator of mouse C/EBPbeta protein isoform production. , 1999, Hepatology.

[48]  Soonkyu Chung,et al.  Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. , 2006, Endocrinology.

[49]  R. A. Forse,et al.  Fat Depot–Specific Characteristics Are Retained in Strains Derived From Single Human Preadipocytes , 2006, Diabetes.

[50]  N. Gerry,et al.  Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. , 2007, American journal of physiology. Endocrinology and metabolism.

[51]  M. Cnop,et al.  Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex , 2003, Diabetologia.

[52]  M. Lane,et al.  Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. , 1992, Genes & development.

[53]  L. Qiang,et al.  Activation of CCAAT/Enhancer-binding Protein (C/EBP) α Expression by C/EBPβ during Adipogenesis Requires a Peroxisome Proliferator-activated Receptor-γ-associated Repression of HDAC1 at the C/ebpα Gene Promoter* , 2006, Journal of Biological Chemistry.

[54]  A. Welm,et al.  Translational induction of liver-enriched transcriptional inhibitory protein during acute phase response leads to repression of CCAAT/enhancer binding protein alpha mRNA. , 2000, The Journal of biological chemistry.

[55]  J. B. Kim,et al.  Down-regulation of Histone Deacetylases Stimulates Adipocyte Differentiation* , 2006, Journal of Biological Chemistry.

[56]  H. Green,et al.  The activation of specific gene transcription in the adipose conversion of 3T3 cells , 1985, Journal of cellular physiology.

[57]  M. Bouxsein,et al.  Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. , 2004, Bone.

[58]  H. Hauner,et al.  The Role of TNF-α in Human Adipose Tissue: Prevention of Weight Gain at the Expense of Insulin Resistance? , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[59]  R. Unger,et al.  The role of leptin resistance in the lipid abnormalities of aging , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  W. Gillon,et al.  Effects of age and anatomic site on preadipocyte number in rat fat depots. , 1994, Journal of Gerontology.

[61]  U. Smith,et al.  Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes. , 2003, Biochemical and biophysical research communications.

[62]  R. DeFronzo.  Dysfunctional fat cells, lipotoxicity and type 2 diabetes , 2004, International journal of clinical practice. Supplement.

[63]  L. Qiang,et al.  Phosphorylation of C/EBPβ at a Consensus Extracellular Signal-Regulated Kinase/Glycogen Synthase Kinase 3 Site Is Required for the Induction of Adiponectin Gene Expression during the Differentiation of Mouse Fibroblasts into Adipocytes , 2004, Molecular and Cellular Biology.

[64]  A. Sniderman,et al.  The adipocyte life cycle hypothesis. , 2006, Clinical science.

[65]  G. Darlington,et al.  CCAAT/enhancer binding protein α (C/EBPα) is an important mediator of mouse C/EBPβ protein isoform production , 1999 .

[66]  B. Spiegelman,et al.  Cross-Regulation of C/EBPα and PPARγ Controls the Transcriptional Pathway of Adipogenesis and Insulin Sensitivity , 1999 .

[67]  M. Pagliassotti,et al.  Adipose tissue-derived tumor necrosis factor activity correlates with fat cell size but not insulin action in aging rats. , 1998, Endocrinology.

[68]  D. Dobson,et al.  Altered expression of C/EBP family members results in decreased adipogenesis with aging. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[69]  K. Uysal,et al.  Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. , 1998, Endocrinology.

[70]  P. Garry,et al.  Changes in anthropometric indices of body composition with age in a healthy elderly population , 1989, American journal of human biology : the official journal of the Human Biology Council.

[71]  S. O’Rahilly,et al.  Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. , 1997, The Journal of clinical investigation.

[72]  Maia M. Jack,et al.  Adiponectin gene activation by thiazolidinediones requires PPARγ2, but not C/EBPα—evidence for differential regulation of the aP2 and adiponectin genes , 2003 .

[73]  J. Stephens,et al.  Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis. , 1992, The Journal of biological chemistry.

[74]  B. Lecka-Czernik,et al.  Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR‐γ2 transcription factor and TGF‐β/BMP signaling pathways , 2004, Aging cell.

[75]  B. Corkey,et al.  Current Views of the Fat Cell as an Endocrine Cell: Lipotoxicity , 2006 .

[76]  K. Siddle,et al.  Human Preadipocytes Display a Depot-Specific Susceptibility to Apoptosis , 1998, Diabetes.

[77]  A. Welm,et al.  CUG repeat binding protein (CUGBP1) interacts with the 5'''' region of C/EBPβ β β β mRNA and regulates translation of C/EBPβ , 1999 .

[78]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[79]  Q. Tang,et al.  Sequential gene promoter interactions of C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis. , 2004, Biochemical and biophysical research communications.

[80]  T. Jenssen,et al.  Oxidative and nonoxidative glucose disposal in elderly vs younger men with similar and smaller body mass indices and waist circumferences. , 2005, Metabolism: clinical and experimental.

[81]  R. Oreffo,et al.  The use of small interfering RNAs to inhibit adipocyte differentiation in human preadipocytes and fetal-femur-derived mesenchymal cells. , 2006, Experimental cell research.

[82]  T. Lash,et al.  Increased CUG Triplet Repeat-binding Protein-1 Predisposes to Impaired Adipogenesis with Aging* , 2006, Journal of Biological Chemistry.

[83]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[84]  R. Hammer,et al.  Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. , 1998, Genes & development.

[85]  X. Wang,et al.  Inhibition of adipogenesis by the stress‐induced protein CHOP (Gadd153). , 1995, The EMBO journal.